{"nct_id":"NCT00391066","title":"Lumiliximab With Fludarabine, Cyclophosphamide, and Rituximab (FCR) Versus FCR Alone in Subjects With Relapsed Chronic Lymphocytic Leukemia (CLL)","status":"TERMINATED","status_verified_date":"2011-04","start_date":"2006-11","start_date_type":null,"primary_completion_date":"2010-07","primary_completion_date_type":"ACTUAL","completion_date":"2010-12","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["BIIB"]}